Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.

Traverse JH, Henry TD, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Forder JR, Byrne BJ, Hatzopoulos AK, Penn MS, Perin EC, Baran KW, Chambers J, Lambert C, Raveendran G, Simon DI, Vaughan DE, Simpson LM, Gee AP, Taylor DA, Cogle CR, Thomas JD, Silva GV, Jorgenson BC, Olson RE, Bowman S, Francescon J, Geither C, Handberg E, Smith DX, Baraniuk S, Piller LB, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moyé LA, Simari RD, Cardiovascular Cell Therapy ResearchNetwork
JAMA. 2011 306 (19): 2110-9

PMID: 22084195 · PMCID: PMC3600981 · DOI:10.1001/jama.2011.1670

MeSH Terms (15)

Adult Aged Angioplasty, Balloon, Coronary Bone Marrow Transplantation Double-Blind Method Female Humans Male Middle Aged Myocardial Infarction Stroke Volume Transplantation, Autologous Treatment Outcome Ventricular Dysfunction, Left Ventricular Function, Left

Connections (1)

This publication is referenced by other Labnodes entities:

Links